Fumaric Acid prices in China fell 0.3% in the last week of October 2025 and 12th consecutive week of decline. Supply is ample and downstream offtake is muted. Maleic Anhydride feedstock costs are weaker, and all major Chinese plants are running at full capacity, adding to inventory pressure. Logistics is smooth and export is consistent but demand from pharmaceuticals, nutraceuticals and food and beverage sectors is sluggish. Importers and manufacturers have big stockpiles, so buyers are adopting short term procurement strategy. The appreciation of RMB also encourages exporters to reduce price to stay competitive, which adds to the downward trend. Market expects November to be soft and prices to go down as demand is restrained and export interest is steady but not supportive. Inventory is ample, raw material cost is falling and restocking is limited, so the fundamentals of Fumaric Acid market is weak and will put mild pressure on prices.
Fumaric Acid prices in China continued to drop in October 2025, the 12th consecutive week of decline, as oversupply, weak domestic offtake and limited export demand persisted. The Fumaric Acid market remained bearish, with weekly price movements only minor against the backdrop of weakening fundamentals. Although upstream costs and operation stability were firm, demand side weakness dominated the month, keeping Fumaric Acid in a prolonged correction.
The Fumaric Acid price drop in October followed the earlier weakness caused by the softening of Maleic Anhydride feedstock in late September. Maleic Anhydride, the main feedstock for Fumaric Acid production, saw significant softening due to abundant benzene and moderate energy prices. This feedstock softening reduced the production cost and removed the upward pressure, but producers continued to run at high utilization rates across China’s large Fumaric Acid capacity. Full capacity operation led to inventory accumulation in the distribution network, leaving sellers with little room to maintain higher offers. As inventory built up, suppliers started to offer discounts to stimulate transactions, which reinforced the bearish tone for Fumaric Acid prices.
Logistics in October were stable. Shanghai port was not disrupted, and FOB shipment was consistent despite the lack of overseas demand. The Chinese yuan continued to appreciate near 7.1/USD, which influenced the market, as exporters adjusted their quotations to remain competitive while protecting their margins. But these measures were not enough to counter the weakening demand, both domestic and international. Export interest of Fumaric Acid from major regions, especially North America and Southeast Asia, was steady but not strong enough to absorb the surplus. Many global Fumaric Acid buyers had sufficient stocks accumulated earlier in the year and were not in urgent need of new procurement.
At domestic front, demand for Fumaric Acid from pharmaceuticals, nutraceuticals and food and beverage sectors was soft. Routine consumption was there but inventory was high among distributors and end-users, so they did not need to buy more Fumaric Acid. Buyers adopted short-cycle procurement strategy, avoiding long-term contracts as they expected the price to remain soft. The U.S.–China tariff truce extension provided trade stability but did not trigger forward buying from international partners. With Fumaric Acid export orders down sharply and domestic market sluggish, the supply and demand gap continued to widen in October.
Despite all this, China’s strong production capacity ensured the supply chain ran smoothly and output was stable even as demand was flat. Fumaric Acid was still used stably in acidulation, beverage formulation and processed food applications, but this base support was not enough to change the overall market trend. The month ended with market participants expecting Fumaric Acid prices to go down.
Looking forward, analysts predict Fumaric Acid prices will drop in November. A small decrease is expected as downstream demand is still restrained and export interest is steady but not enough to offset the weaker domestic offtake of Fumaric Acid. Market fundamentals will be soft and Fumaric Acid quotations will be under mild pressure as buyers are still cautious in their procurement.
